HER2

You have access
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose ²¹¹At-Labeled Anti-HER2 Single-Domain Antibody Fragment
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky

Journal of Nuclear Medicine January 1, 2023, 64 (1) 124-130; DOI: https://doi.org/10.2967/jnumed.122.264071
You have access
Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts
Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, Yongsheng Liu, Olga Vorontsova, Tianqi Xu, Kristina Westerlund, Anna Orlova, Vladimir Tolmachev and Amelie Eriksson Karlström

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1046-1051; DOI: https://doi.org/10.2967/jnumed.121.262123
You have access
Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer
Olga Bragina, Vladimir Chernov, Alexey Schulga, Elena Konovalova, Eugeniy Garbukov, Anzhelika Vorobyeva, Anna Orlova, Liubov Tashireva, Jens Sörensen, Roman Zelchan, Anna Medvedeva, Sergey Deyev and Vladimir Tolmachev

Journal of Nuclear Medicine April 1, 2022, 63 (4) 528-535; DOI: https://doi.org/10.2967/jnumed.121.262542
You have access
Site-Specific and Residualizing Linker for ¹⁸F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky and Ganesan Vaidyanathan

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1624-1630; DOI: https://doi.org/10.2967/jnumed.120.261446
You have access
Utility of ²¹¹At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu and Sumitaka Hasegawa

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1468-1474; DOI: https://doi.org/10.2967/jnumed.120.249300
You have access
Phase I Study of ^99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer
Olga Bragina, Emma von Witting, Javad Garousi, Roman Zelchan, Mattias Sandström, Anna Orlova, Anna Medvedeva, Artem Doroshenko, Anzhelika Vorobyeva, Sarah Lindbo, Jesper Borin, Natalya Tarabanovskaya, Jens Sörensen, Sophia Hober, Vladimir Chernov and Vladimir Tolmachev

Journal of Nuclear Medicine April 1, 2021, 62 (4) 493-499; DOI: https://doi.org/10.2967/jnumed.120.248799
Open Access
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
Patrícia M.R. Pereira, Komal Mandleywala, Ashwin Ragupathi, Lukas M. Carter, Jeroen A.C.M. Goos, Yelena Y. Janjigian and Jason S. Lewis

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1569-1578; DOI: https://doi.org/10.2967/jnumed.119.225813
You have access
Development of ⁶⁴Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies
Sang-Keun Woo, Su Jin Jang, Min-Jung Seo, Ju Hui Park, Byoung Soo Kim, Eun Jung Kim, Yong Jin Lee, Tae Sup Lee, Gwang Il An, In Ho Song, Youngho Seo, Kwang Il Kim and Joo Hyun Kang

Journal of Nuclear Medicine January 1, 2019, 60 (1) 26-33; DOI: https://doi.org/10.2967/jnumed.118.210294
You have access
Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging
Longguang Tang, Chenyu Peng, Bowen Tang, Zijing Li, Xiangyu Wang, Jindian Li, Fei Gao, Lumei Huang, Duo Xu, Pu Zhang, Rongqiang Zhuang, Xinhui Su, Xiaoyuan Chen and Xianzhong Zhang

Journal of Nuclear Medicine September 1, 2018, 59 (9) 1386-1391; DOI: https://doi.org/10.2967/jnumed.117.205088
You have access
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion de Jong, Anna Orlova, Johanna Mattsson, Patrick Micke, Amelie Eriksson Karlström and Vladimir Tolmachev

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1092-1098; DOI: https://doi.org/10.2967/jnumed.118.208348

Main menu

User menu

Search

HER2

Pages